Literature DB >> 18929412

High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.

Michael Green1, Maher K Gandhi, Emily Camilleri, Paula Marlton, Rod Lea, Lyn Griffiths.   

Abstract

The t(14;18)(q21;q34) BCL2 translocation is a common genetic alteration in follicular and diffuse large B-cell lymphoma. However, it is not invariably associated with BCL2 gene overexpression due to undefined mechanisms that regulate expression from the proximal immunoglobulin heavy-chain (IgH) promoter. The BACH2 transcriptional repressor is able to modulate activity of this promoter. Here we have shown that, in tumor samples with BCL2 translocation, those with high levels of BACH2 had significantly lower BCL2 transcript abundance compared to those with low levels of BACH2. This indicates that BACH2 may be partially responsible for regulation of BCL2 expression from the t(14;18)(q21;q34) translocation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929412     DOI: 10.1016/j.leukres.2008.09.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

Review 1.  BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.

Authors:  Srividya Swaminathan; Cihangir Duy; Markus Müschen
Journal:  Trends Immunol       Date:  2013-12-10       Impact factor: 16.687

Review 2.  Nature and importance of follicular lymphoma precursors.

Authors:  Emilie Mamessier; Florence Broussais-Guillaumot; Bruno Chetaille; Reda Bouabdallah; Luc Xerri; Elaine S Jaffe; Bertrand Nadel
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

3.  Extensive gene-specific translational reprogramming in a model of B cell differentiation and Abl-dependent transformation.

Authors:  Jamie G Bates; Julia Salzman; Damon May; Patty B Garcia; Gregory J Hogan; Martin McIntosh; Mark S Schlissel; Pat O Brown
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.